These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8093870)

  • 41. Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine.
    Savarino V; Mela GS; Zentilin P; Cutela P; Vigneri S; Termini R; Di Mario F; Ferrana M; Malesci A; Belicchi M; Celle G
    Fundam Clin Pharmacol; 1996; 10(3):304-8. PubMed ID: 8836705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-steroidal anti-inflammatory drug ingestion: retrospective study of 272 bleeding or perforated peptic ulcers.
    Smedley FH; Taube M; Leach R; Wastell C
    Postgrad Med J; 1989 Dec; 65(770):892-5. PubMed ID: 2616429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ranitidine in the treatment of duodenal ulceration.
    Peden NR; Boyd EJ; Saunders JH; Wormsley KG
    Scand J Gastroenterol; 1981 Apr; 16(3):325-9. PubMed ID: 16435471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. History in our lifetime: the changing nature of refractory duodenal ulcer in the era of histamine H2 receptor antagonists.
    Bardhan KD; Nayyar AK; Royston C
    Dig Liver Dis; 2003 Aug; 35(8):529-36. PubMed ID: 14567455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ranitidine in the treatment of duodenal ulcer disease: relationship between antisecretory effect and ulcer healing rate.
    McIsaac RL; Dixon JS; Mills JG; Wood JR
    Aliment Pharmacol Ther; 1991 Jun; 5(3):227-43. PubMed ID: 1888823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On the natural history of peptic ulcer.
    Lindell G; Celebioglu F; Von Holstein CS; Graffner H
    Scand J Gastroenterol; 1994 Nov; 29(11):979-82. PubMed ID: 7871377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gastric acid secretion in patients with prepyloric ulcer and with combined gastric and duodenal ulcer.
    Dahlgren S; Nordgren B
    Acta Chir Scand; 1976; 142(8):599-604. PubMed ID: 1032067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of perforated and bleeding peptic ulcers before and after the introduction of H2-receptor antagonists.
    Christensen A; Bousfield R; Christiansen J
    Ann Surg; 1988 Jan; 207(1):4-6. PubMed ID: 2892468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Acute hemorrhage caused by duodenal ulcer. Results of endoscopic treatment of the first bleeding episode and of recurrences].
    de Manzoni G; Catalano F; Festini M; Guglielmi A; Lombardo F; Kind R; Rodella L; Ruzzenente A; Zerman G
    Ann Ital Chir; 2002; 73(4):387-94; discussion 394-6. PubMed ID: 12661227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recurrent giant longitudinal duodenal ulcer with massive hemorrhage in a Helicobacter pylori-negative patient.
    Fujimoto M; Shimizu I; Horie T; Inoue H; Okazaki M; Niki M; Shiraishi T; Fujiwara S; Murata M; Yamamoto K; Iuchi A; Hino A; Ito S
    J Med Invest; 2001 Aug; 48(3-4):210-5. PubMed ID: 11694961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can higher doses of an H2-receptor antagonist accelerate duodenal ulcer healing?
    Page MC; Lacey LA; Mills JG; Wood JR
    Aliment Pharmacol Ther; 1989 Oct; 3(5):425-33. PubMed ID: 2577498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endoscopic assessment of blood flow in duodenal ulcers.
    Leung FW; Wong DN; Lau J; Bondoc EM; Hsu R; Leung JW
    Gastrointest Endosc; 1994; 40(3):334-41. PubMed ID: 8056237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence and pattern of peptic ulcer bleeding in a defined geographical area. DUSUK Study Group.
    Ohmann C; Thon K; Hengels KJ; Imhof M
    Scand J Gastroenterol; 1992 Jul; 27(7):571-81. PubMed ID: 1641583
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ranitidine therapy in patients with idiopathic gastric acid hypersecretion. A prospective study.
    Collen MJ; Wirshup JF
    Dig Dis Sci; 1995 Aug; 40(8):1687-90. PubMed ID: 7648968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparative studies of peptic ulcer in the active stage with and without hemorrhage].
    Dimitrov B; Vladimirov B; Voĭnov N; Atanasov B; Korukov B
    Vutr Boles; 1989; 28(5):53-8. PubMed ID: 2618009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Twenty-four-hour intragastric acidity and clinical trial of bedtime enprostil 70 micrograms compared with ranitidine 300 mg in duodenal ulcer.
    Walt RP; Pounder RE; Hawkey CJ; Santana IA; Somerville KW; Logan RF; Long RG; Langman MJ
    Aliment Pharmacol Ther; 1987 Apr; 1(2):161-6. PubMed ID: 2979218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of a new histamine H2-receptor antagonist, ranitidine, on experimental acute gastric and duodenal ulcers (author's transl)].
    Okabe S; Kunimi H; Ohtsuki H
    Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):397-406. PubMed ID: 6116654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Maintenance of gastric pH above 6 with intravenous famotidine in patients with a bleeding duodenal ulcer.
    Delchier JC; el Amine I; Roudot-Thoraval F; Elouaer-Blanc L; Lamarque D; Stanescu L
    Aliment Pharmacol Ther; 1995 Apr; 9(2):191-6. PubMed ID: 7605861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Failure of endoscopic therapy in upper gastrointestinal hemorrhage due to duodenal ulcers.
    López Vallejos P; García Sánchez MV; González Galilea A; Gálvez Calderón C; Naranjo Rodríguez A; Montero Alvarez JL; de Dios Vega JF
    Rev Esp Enferm Dig; 2003 Oct; 95(10):700-6, 692-9. PubMed ID: 14588064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease.
    Penston JG; Wormsley KG
    Aliment Pharmacol Ther; 1992 Oct; 6(5):629-45. PubMed ID: 1420753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.